查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球骨盆器官脱垂修復市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按治疗、按应用、按最终用户、按地区
市场调查报告书
商品编码
1385633

全球骨盆器官脱垂修復市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按治疗、按应用、按最终用户、按地区

Pelvic Organ Prolapse Repair Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 233 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球骨盆器官脱垂（POP）修復市场规模持续大幅成长，预计2024年销售额将达4.2亿美元。 该市场预计将以 5.23% 的复合年增长率扩张，到 2031 年底将达到 6 亿美元。 该市场的成长是由女性骨盆底疾病盛行率上升以及製造商专注于开发安全、有效和持久的治疗方法所推动的。

越来越多的女性患有骨盆底疾病，如阴道脱垂、尿失禁、间质性膀胱炎和瘘管。 这些疾病正在推动对手术和非手术骨盆器官脱垂修復治疗的需求。

包括机器人手术在内的微创手术正在取代传统治疗方法。 这些手术恢復时间快，併发症也少。 骨盆底修復中与合成网片相关的併发症引发了对生物材料和细胞疗法的研究，预计这将对市场产生积极影响。

製造商正在投资研发，以改善骨盆器官脱垂修復的治疗选择，同时最大限度地降低风险和副作用。 这些创新，包括使用各种细胞系的组织工程，有望为患者带来更好的治疗结果。

製造商正在透过与医疗机构合作并进入骨盆底併发症高发地区来扩大市场范围。 我们也致力于教育活动，以提高患者对骨盆底状况和可用治疗的认识。

由于女性骨盆底疾病的盛行率较高，美国在全球骨盆器官脱垂修復市场中占有很大份额。 成熟的行业参与者和不断增长的患者人数正在为市□□场扩张做出贡献。

中国人口众多，接受POP修復手术的患者也很多。 对医疗保健基础设施和先进医疗技术的投资正在吸引来自全国各地和邻国的患者，推动市场成长。

德国对医疗保健研究和开发的关注正在推动 POP 修復治疗的创新。 医疗保健提供者和製造商之间的合作以及特定区域的策略正在促进市场扩张。

本报告调查了全球骨盆器官脱垂修復市场，并按治疗方法、应用、最终用户、地区以及进入市场的公司的竞争趋势提供了市场概述、趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2031年全球骨盆腔器官脱垂修復市场展望

  • 2018-2031 年全球骨盆器官脱垂修復市场前景（按治疗方法划分）、价值（百万美元）
  • 2018-2031 年全球骨盆腔器官脱垂修復市场前景（按应用、价值（百万美元））
  • 2018-2031 年全球骨盆器官脱垂修復市场前景（按最终用户划分）价值（百万美元）
  • 2018-2031 年全球骨盆腔器官脱垂修復市场前景（按地区、价值（百万美元））

第四章北美骨盆腔器官脱垂修復市场展望，2018-2031

第五章欧洲骨盆器官脱垂修復市场展望，2018-2031

第六章亚太盆腔器官脱垂修復市场展望，2018-2031

第 7 章拉丁美洲骨盆器官脱垂修復市场展望，2018-2031

第 8 章中东与非洲骨盆器官脱垂修復市场展望，2018-2031

第九章竞争态势

  • 按製造商和应用程式划分的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Johnson & Johnson Services, Inc.
    • Coloplast A/S
    • Dipromed Srl
    • Boston Scientific Corporation (American Medical Systems Inc.)
    • PFM medical ag
    • Promedon Group
    • Caldera Medical
    • Cook Medical
    • Medgyn Products, Inc.
    • Cooper Surgical, Inc.
    • DIMA S.L.
    • Digitimer Ltd.
    • Bray Group Ltd.
    • Medesign Ingenieur-Consulting GmbH
    • Panpac Medical Corp.

第 10 章附录

简介目录

The global pelvic organ prolapse (POP) repair market continues to witness substantial growth, with a revenue of US$ 420 million in 2024. It is projected to expand at a CAGR of 5.23%, reaching a valuation of US$ 600 million by the end of 2031. The market's growth is driven by the rising prevalence of pelvic floor disorders among women and manufacturers' focus on developing safe, effective, and long-lasting treatment options.

Key Drivers of the Pelvic Organ Prolapse Repair Market

Prevalence of Pelvic Floor Disorders: An increasing number of women are experiencing pelvic floor conditions such as vaginal prolapse, urinary incontinence, interstitial cystitis, and fistulae. These conditions are driving the demand for pelvic organ prolapse repair treatments, both surgical and non-surgical.

Minimally Invasive Techniques: Minimally invasive surgeries, including robotic procedures, are replacing traditional treatment methods. These procedures offer faster recovery and fewer complications. The complications associated with synthetic mesh in pelvic floor repair have led to research into biomaterials and cell-based therapies, which are anticipated to positively impact the market.

Research and Development: Manufacturers are investing in research and development efforts to improve treatment options for pelvic organ prolapse repair while minimizing risks and side effects. These innovations, including tissue engineering with various cell lines, promise better outcomes for patients.

Geographical Expansions: Manufacturers are expanding their market reach by collaborating with healthcare organizations and entering regions with a high prevalence of pelvic floor complications. They are also engaging in educational initiatives to raise awareness among patients about pelvic floor conditions and available treatments.

Barriers to Market Growth

Stringent Regulations: Stringent regulations and product recalls related to pelvic reconstruction have limited the availability of products. Reported side effects such as mesh erosion, infections, vaginal scarring, and recurrent urine incontinence have led to heightened scrutiny by regulatory bodies.

Availability of Non-Surgical Options: Some patients prefer non-surgical and conservative treatments such as pelvic floor exercises, pessaries, and physical therapy. The availability of these non-invasive options affects the demand for surgical procedures.

Limited Patient Awareness: Limited knowledge of pelvic floor conditions and available treatments among patients and healthcare workers has resulted in cases of undiagnosed and untreated POP.

Country-wise Market Insights

United States: The United States accounts for a significant share of the global pelvic organ prolapse repair market due to the high prevalence of pelvic floor disorders among women. Established industry players and a growing patient population contribute to market expansion.

China: China's large population results in a substantial patient pool for POP repair surgeries. Investments in healthcare infrastructure and advanced medical technologies are attracting patients from within the country and nearby nations, driving market growth.

Germany: Germany's strong emphasis on research and development in healthcare fosters innovation in POP repair treatments. Collaborations between healthcare providers and manufacturers, along with region-specific strategies, contribute to market expansion.

Competition Landscape

The pelvic organ prolapse repair market is highly competitive, with numerous local competitors offering products and services. Key players are focusing on research and development, expansion, and partnerships to meet patient demands and expand their market presence.

Key Companies Leading the Pelvic Organ Prolapse Repair Market:

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation (American Medical Systems Inc.)
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical
  • Medgyn Products, Inc.
  • CooperSurgical, Inc.
  • DIMA S.L.
  • Digitimer Ltd.
  • Bray Group Ltd.
  • Medesign Ingenieur-Consulting GmbH
  • Panpac Medical Corp.
  • For.me.sa.
  • Bioteque America Inc.
  • Bliss GVS Pharma
  • Panpac Medical Corporation
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co.
  • Kangge Medical
  • Integra Lifesciences
  • Wallach Surgical Devices
  • Medesign

Key Segments of Pelvic Organ Prolapse Repair Industry Research

Treatment:

  • Non-surgical
    • Pessary
    • Pelvic Floor Muscle Therapy
  • Surgical
    • Colpocleisis
    • Colporrhaphy
    • Sacrocolpopexy
    • Sacrohysteropexy
    • Uterosacral or Sacrospinous Ligament Fixation

Application:

  • Cystocele
  • Urethrocele
  • Enterocele
  • Uterine Prolapse
  • Posterior Vaginal Wall Prolapse (Dropped Rectum)

End User:

  • Hospitals
  • Specialized Clinics
  • Female Care Facilities

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 3.1. Global Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Non-surgical
        • 3.1.1.1.1. Pessary
        • 3.1.1.1.2. Pelvic Floor Muscle Therapy
      • 3.1.1.2. Surgical
        • 3.1.1.2.1. Colpocleisis
        • 3.1.1.2.2. Colporrhaphy
        • 3.1.1.2.3. Sacrocolpopexy
        • 3.1.1.2.4. Sacrohysteropexy
        • 3.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 3.2. Global Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cystocele
      • 3.2.1.2. Urethrocele
      • 3.2.1.3. Enterocele
      • 3.2.1.4. Uterine Prolapse
      • 3.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 3.3. Global Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialized Clinics
      • 3.3.1.3. Female Care Facilities
  • 3.4. Global Pelvic Organ Prolapse Repair Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 4.1. North America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. By Treatment
        • 4.1.1.1.1. Pessary
        • 4.1.1.1.2. Pelvic Floor Muscle Therapy
      • 4.1.1.2. Surgical
        • 4.1.1.2.1. Colpocleisis
        • 4.1.1.2.2. Colporrhaphy
        • 4.1.1.2.3. Sacrocolpopexy
        • 4.1.1.2.4. Sacrohysteropexy
        • 4.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 4.2. North America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cystocele
      • 4.2.1.2. Urethrocele
      • 4.2.1.3. Enterocele
      • 4.2.1.4. Uterine Prolapse
      • 4.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 4.3. North America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialized Clinics
      • 4.3.1.3. Female Care Facilities
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 5.1. Europe Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. By Treatment
        • 5.1.1.1.1. Pessary
        • 5.1.1.1.2. Pelvic Floor Muscle Therapy
      • 5.1.1.2. Surgical
        • 5.1.1.2.1. Colpocleisis
        • 5.1.1.2.2. Colporrhaphy
        • 5.1.1.2.3. Sacrocolpopexy
        • 5.1.1.2.4. Sacrohysteropexy
        • 5.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 5.2. Europe Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cystocele
      • 5.2.1.2. Urethrocele
      • 5.2.1.3. Enterocele
      • 5.2.1.4. Uterine Prolapse
      • 5.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 5.3. Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialized Clinics
      • 5.3.1.3. Female Care Facilities
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Pelvic Organ Prolapse Repair Market By Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Pelvic Organ Prolapse Repair Market By Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. By Treatment
        • 6.1.1.1.1. Pessary
        • 6.1.1.1.2. Pelvic Floor Muscle Therapy
      • 6.1.1.2. Surgical
        • 6.1.1.2.1. Colpocleisis
        • 6.1.1.2.2. Colporrhaphy
        • 6.1.1.2.3. Sacrocolpopexy
        • 6.1.1.2.4. Sacrohysteropexy
        • 6.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 6.2. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cystocele
      • 6.2.1.2. Urethrocele
      • 6.2.1.3. Enterocele
      • 6.2.1.4. Uterine Prolapse
      • 6.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 6.3. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialized Clinics
      • 6.3.1.3. Female Care Facilities
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 7.1. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. By Treatment
        • 7.1.1.1.1. Pessary
        • 7.1.1.1.2. Pelvic Floor Muscle Therapy
      • 7.1.1.2. Surgical
        • 7.1.1.2.1. Colpocleisis
        • 7.1.1.2.2. Colporrhaphy
        • 7.1.1.2.3. Sacrocolpopexy
        • 7.1.1.2.4. Sacrohysteropexy
  • 7.2. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Cystocele
      • 7.2.1.2. Urethrocele
      • 7.2.1.3. Enterocele
      • 7.2.1.4. Uterine Prolapse
      • 7.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 7.3. Latin America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialized Clinics
      • 7.3.1.3. Female Care Facilities
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. By Treatment
        • 8.1.1.1.1. Pessary
        • 8.1.1.1.2. Pelvic Floor Muscle Therapy
      • 8.1.1.2. Surgical
        • 8.1.1.2.1. Colpocleisis
        • 8.1.1.2.2. Colporrhaphy
        • 8.1.1.2.3. Sacrocolpopexy
        • 8.1.1.2.4. Sacrohysteropexy
        • 8.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 8.2. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cystocele
      • 8.2.1.2. Urethrocele
      • 8.2.1.3. Enterocele
      • 8.2.1.4. Uterine Prolapse
      • 8.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 8.3. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialized Clinics
      • 8.3.1.3. Female Care Facilities
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Johnson & Johnson Services, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Coloplast A/S
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Dipromed Srl
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Boston Scientific Corporation (American Medical Systems Inc.)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. PFM medical ag
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Promedon Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Caldera Medical
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Cook Medical
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Medgyn Products, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Cooper Surgical, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. DIMA S.L.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Digitimer Ltd.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Bray Group Ltd.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Medesign Ingenieur-Consulting GmbH
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Panpac Medical Corp.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations